Clinical trials
Completed Pneumonia trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 17 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 9 |
| Nantes University Hospital | 7 |
| Bayer | 4 |
| Hospices Civils de Lyon | 4 |
| University Hospital, Toulouse | 4 |
| Aridis Pharmaceuticals, Inc. | 3 |
| CHU de Reims | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 3 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Groupe Hospitalier Pitie-Salpetriere | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia | 73 |
| COVID-19 | 12 |
| Pneumonia, Ventilator-Associated | 8 |
| Community-Acquired Pneumonia | 7 |
| Pseudomonas Infections | 4 |
| Respiratory Distress Syndrome | 4 |
| Bacterial Infections | 3 |
| Coronavirus Infections | 3 |
| Pneumonia, Bacterial | 3 |
| Staphylococcal Infections | 3 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.